Loading
Latest filing published 17 May 2023 for iSpecimen Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jill Mullan, listed as senior executive, appears in our data through filings on iSpecimen Inc. shares, published by SEC (Form 4). In total, 8 filings cover trades dated from 21 June 2021 to 17 January 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 17 May 2023 came the latest disclosure, a share grant in iSpecimen Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations